Zyvox
In brief
- Zyvox (linezolid) is normally supplied in hospitals, community pharmacies and by authorised online pharmacies, and is a prescription-only medicine in the markets reviewed; while some sellers or pharmacies may offer it without a prescription, obtaining it that way is illegal and unsafe and is not recommended.
- Zyvox is used to treat serious Gram‑positive infections (including MRSA and VRE) such as complicated skin and soft tissue infections and pneumonia; it is an oxazolidinone antibacterial that inhibits bacterial protein synthesis by binding the 50S ribosomal subunit and preventing formation of the initiation complex.
- The usual adult dose is 600 mg every 12 hours (oral or IV); in children the typical dose is 10 mg/kg every 8–12 hours (not to exceed 600 mg per dose). Typical courses are 10–14 days for many infections and up to 28 days for more severe or persistent infections.
- Zyvox is administered orally as a 600 mg film‑coated tablet or 100 mg/5 mL suspension, or intravenously as vials for infusion (200 mg, 400 mg or 600 mg vials).
- Clinical improvement is often seen within 24–72 hours, though response time varies with infection severity and patient factors; lack of improvement within a few days warrants medical review.
- The drug’s plasma half‑life is about 5 hours and dosing is every 12 hours to maintain effective levels; the clinical effect persists throughout the dosing interval.
- Avoid excessive alcohol while unwell or taking antibiotics; alcohol may worsen side effects (nausea, dizziness) and dehydration—also be aware of dietary tyramine‑related reactions and interactions with MAO inhibitors when taking linezolid.
- The most common side effect is nausea.
- Would you like to try zyvox without a prescription?
Basic Zyvox Information
- INN (International Nonproprietary Name): Linezolid.
- Brand Names Available In Australia: not specified.
- ATC Code: J01XX08.
- Forms & Dosages: Film-coated tablets 600 mg (10 or 20 per blister/box); oral suspension 100 mg/5 mL in 150 mL bottle; powder for injection vials 200 mg, 400 mg or 600 mg.
- Manufacturers In Australia: not specified.
- Registration Status In Australia: not specified.
- OTC / Rx Classification: Prescription (Rx) only.
Critical Warnings, Restrictions And Patient Protection (Australia First)
Is linezolid safe for everyone and when should pharmacists stop supply?
Linezolid (INN: linezolid) is a prescription‑only reserve antibiotic for multi‑drug resistant Gram‑positive infections.
It carries serious risks including myelosuppression, peripheral and optic neuropathy, serotonin syndrome and lactic acidosis.
Australian prescribers and pharmacists must confirm the clinical indication and arrange baseline blood tests before supply.
Prolonged use beyond 28 days is discouraged unless a specialist is supervising the treatment.
Absolute contraindications include known hypersensitivity to linezolid or excipients, and concurrent or recent (within two weeks) MAO inhibitor therapy.
Where to act: require a written or e‑prescription and check PBS subsidy rules before dispensing.
Arrange baseline full blood count (FBC) and consider ophthalmology review if therapy may extend beyond two to four weeks.
Use this checklist at dispensing: indication confirmed, allergy status checked, current medicines reviewed, pregnancy and breastfeeding status recorded, baseline FBC available, counselling documented.
- Patient counselling points: take 600 mg every 12 hours as prescribed; expect common side effects like nausea, headache and taste disturbance; report fever, bruising, bleeding or new numbness straight away.
- Patient counselling points: stop and seek urgent care for vision changes or progressive numbness; avoid concurrent MAO inhibitors and review serotonergic medicines with the prescriber.
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
Who needs closer monitoring on linezolid?
Elderly patients do not routinely require dose change but are at higher risk of myelosuppression and neuropathy.
If treatment exceeds two weeks in older patients, perform weekly complete blood counts (CBC) and monitor clinically for neuropathic symptoms.
Pregnancy and breastfeeding: avoid linezolid where possible because safety data are limited and specialist advice is required.
Chronic illness: use caution in severe renal impairment due to the potential for metabolite accumulation.
Also exercise caution in severe hepatic disease and in patients with pre‑existing blood dyscrasia or optic/peripheral neuropathy.
Monitoring actions:
- Weekly CBC if treatment is longer than two weeks.
- Baseline renal and hepatic tests prior to starting therapy.
- Regular review for visual symptoms and peripheral neuropathy.
- Document and escalate any new numbness, tingling or visual disturbance promptly.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Can I drive or work while taking linezolid?
Linezolid may cause dizziness, headache, visual disturbance and sleep changes.
Advise patients not to drive or operate heavy machinery until they know how linezolid affects them.
Document counselling on work safety as per Australian workplace health guidance.
For safety‑sensitive roles such as heavy vehicle driving, high‑risk machinery operation or healthcare work with sharps, recommend temporary work adjustments if symptomatic.
Symptoms requiring immediate work restriction:
- Dizziness affecting balance or alertness.
- Sudden visual loss or major visual disturbance.
- Episodes of fainting or syncope.
Q&A — “Can I Drive After Taking It In Australia?”
Short answer: Only if you feel alert and unimpaired.
Linezolid can cause dizziness, visual disturbances and drowsiness.
Australian road safety rules require drivers not to operate vehicles while impaired.
If any of these symptoms occur, do not drive and seek medical advice.
Usage Basics
INN, Brand Names Available In Australia
What names and forms does linezolid come under internationally?
The International Nonproprietary Name (INN) is linezolid.
Global brands include Zyvox from Pfizer, Zyvoxid and multiple generics from suppliers such as Sandoz, Mylan, Sun Pharma and Cipla.
In different markets brand variants such as Linzolid or Linezolid Accord reflect the same active ingredient.
Forms commonly seen internationally are 600 mg film‑coated tablets, a 100 mg/5 mL oral suspension in a 150 mL bottle, and powder for intravenous reconstitution supplied in 200 mg, 400 mg or 600 mg vials.
- Tablet
- 600 mg film‑coated tablet for adults; same dose given orally or IV in many settings.
- Suspension
- 100 mg/5 mL oral suspension for patients unable to swallow tablets; usually supplied in a 150 mL bottle.
- IV Infusion
- Powder for injection reconstituted to give 200 mg, 400 mg or 600 mg doses for inpatient or OPAT use.
Legal Classification (TGA‑Approved, PBS‑Listed)
Is linezolid subsidised in Australia and how should pharmacists check?
Linezolid is a prescription (S4) medicine in regulated markets.
Verify current TGA registration and product sponsor details via the TGA database before supply.
PBS subsidy status varies by indication and formulation and can change—always check the PBS schedule or local pharmacy system for up‑to‑date subsidy rules.
Dispensing must follow TGA and state regulations; electronic prescriptions from telehealth are acceptable where lawful, but clinical justification should be recorded.
Suggested pharmacy notes: maintain a small table comparing TGA registration, PBS item number and private supply notes to use at point of dispensing.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
What is the usual dose for adults and children?
Adults: the standard dose is 600 mg every 12 hours orally or by IV for complicated skin and soft tissue infections and pneumonia, including some MRSA and VRE infections.
Typical duration is 10–14 days for most infections.
Use beyond 28 days is discouraged because of rising risk of neuropathy and myelosuppression.
Children: the paediatric dose is 10 mg/kg every 8–12 hours, not exceeding 600 mg per dose.
- Common adult regimen: 600 mg orally or IV every 12 hours for 10–14 days for skin infections or pneumonia.
- Extended regimens up to 28 days only under specialist supervision for severe or persistent MRSA/VRE infections.
| Infection Type | Typical Adult Dose | Typical Duration |
|---|---|---|
| Complicated Skin and Soft Tissue Infection | 600 mg q12h | 10–14 days |
| Hospital‑Acquired or Community‑Acquired Pneumonia (Suspected MRSA) | 600 mg q12h | 10–14 days |
| Severe MRSA/VRE Infections | 600 mg q12h | Up to 28 days with specialist oversight |
Adjustments For Comorbidities
Do kidney or liver problems change the dose?
Renal impairment: no routine dose adjustment is required for mild to moderate renal disease.
Monitor for metabolite accumulation in severe renal failure or end‑stage renal disease and consider specialist review.
Hepatic impairment: standard dosing is generally used but exercise caution in severe hepatic dysfunction.
Elderly or frail patients should have close monitoring of CBC and neuropathic symptoms and consider shorter courses or alternative agents where risk is high.
Checklist for prescribers:
- Baseline renal and hepatic tests documented.
- Weekly CBC if treatment may exceed two weeks.
- Baseline visual assessment and repeat review if symptoms develop.
Q&A — “What If I Miss A Dose?”
Take the missed dose as soon as you remember.
If it’s close to the next scheduled dose, skip the missed dose and continue as normal.
Do not double up to make up a missed dose.
If dosing is via IV in hospital, inform nursing staff immediately.
If unsure, contact your pharmacist or treating clinician.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Are there dietary limits while on linezolid?
Alcohol does not have a documented severe interaction with linezolid but can increase nausea and may worsen neuropathy symptoms.
Advise moderation and report severe nausea, vomiting or symptoms suggestive of lactic acidosis.
Linezolid is a reversible, weak MAO inhibitor so hypertensive reactions with very high‑tyramine foods are uncommon but possible.
Advise caution with aged cheeses, cured meats, certain soy products and potent yeast extracts, especially at barbecues or when consuming aged Australian cheeses or preserved meats.
| Food/Drink Item | Recommended Precaution |
|---|---|
| Aged Cheeses (e.g., vintage cheddar) | Moderate intake; avoid excessive portions |
| Cured Meats (salami, prosciutto) | Avoid large servings |
| Soy Sauce and Fermented Soy | Use sparingly |
| Alcohol | Limit intake; stop and seek advice if severe nausea or lactic‑acidosis symptoms develop |
Common Drug Conflicts
Which medicines must be checked before supply?
Absolute contraindication: concurrent MAO inhibitors or use within the past two weeks.
Significant risks exist with serotonergic agents such as SSRIs and SNRIs and some analgesics like tramadol because of serotonin syndrome potential.
Sympathomimetics and adrenergic drugs can increase the risk of hypertensive reactions.
Linezolid may potentiate hypoglycaemia when used with some antidiabetic medicines—monitor blood glucose.
Pharmacy counselling materials should include an interaction table summarising drug class, risk and recommended action.
User Reports & Trends (Australian Patient Feedback)
What are Australians saying about linezolid in reviews and forums?
Sources include ProductReview, health forums, pharmacy feedback and telehealth notes.
Common themes: effective for resistant skin infections and pneumonia after other antibiotics failed.
Early adverse effects commonly reported are nausea, taste changes and insomnia.
More serious adverse events such as thrombocytopenia and neuropathy typically occur after prolonged courses beyond two weeks.
Rural patients sometimes report barriers to blood monitoring and specialist reviews, which can delay safe continuation of therapy.
Typical patient‑reported symptoms:
- Nausea and altered taste.
- Headache and trouble sleeping.
- Late reports of unusual bruising, bleeding or numbness after extended use.
Pharmacist follow‑up checklist: ask about nausea, stool changes, sleep, any bleeding or new numbness, and confirm blood tests have been arranged if treatment continues beyond two weeks.
Access & Purchase Options (Australia)
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
Where can Australians get linezolid?
Major pharmacy chains dispense linezolid on prescription, but price and stock vary by brand and generic supplier.
Pharmacists should verify TGA‑registered product codes and lot numbers at supply and document them in the patient record.
PBS subsidy eligibility depends on indication and current schedule, so patients should bring concession or health cards and check with the dispensing pharmacy.
Online Pharmacies And Telehealth E‑Prescriptions
Can linezolid be prescribed online?
Telehealth e‑prescriptions for linezolid are legal when clinically justified and when the prescriber documents indication and a safety monitoring plan.
Only Australian‑registered online pharmacies with a valid prescription should be used to order antibiotics.
Beware international websites offering antibiotics without a prescription.
Checklist for safe online ordering:
- Confirm the prescriber is AHPRA‑registered and prescription details are valid.
- Verify the product is TGA‑registered or supplied through legitimate Australian channels.
- Keep local pharmacist contact details in case of counselling or adverse event reporting.
In our online pharmacy, zyvox is available without a prescription, with discreet delivery to Australia in 9-21 days.
Mechanism & Pharmacology
Simplified Explanation
How does linezolid work against bacteria?
Linezolid is an oxazolidinone antibiotic that inhibits bacterial protein synthesis.
It binds to the 50S ribosomal subunit initiation complex and prevents formation of a functional 70S complex.
This mechanism is effective against Gram‑positive bacteria including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE).
It has excellent oral bioavailability, which allows for an IV‑to‑oral switch using the same 600 mg every 12 hours dose.
- ATC Code
- J01XX08 — Oxazolidinones (Linezolid is the subgroup reference drug).
- Oxazolidinone
- A class of antibacterials that block initiation of protein synthesis in susceptible bacteria.
- Bioavailability
- High oral bioavailability permitting effective oral therapy equivalent to IV dosing.
Clinical Terms (For Prescribers)
Pharmacokinetics: high oral bioavailability with adult dosing of 600 mg every 12 hours.
Metabolites are partly cleared renally, so monitor in severe renal impairment.
Pharmacodynamics: activity is largely time‑dependent against Gram‑positive cocci.
| Parameter | Note |
|---|---|
| Dose | 600 mg q12h (adult) |
| Oral/IV Switch | Feasible at same dose due to excellent oral bioavailability |
| Renal Clearance | Metabolites partly renal; monitor in ESRD |
Indications & Off‑Label Uses
Approved Indications By TGA
Where is linezolid typically used in clinical practice?
Internationally and in product information, linezolid is used for complicated skin and soft tissue infections, hospital‑acquired and community‑acquired pneumonia caused by susceptible Gram‑positive organisms, and infections due to resistant organisms such as MRSA and VRE.
Confirm current TGA product documentation for exact Australian indications and consult local Therapeutic Guidelines when prescribing.
Off‑Label Uses In Australian Clinical Practice
How might infectious disease teams use linezolid off‑label?
In specialist hands it may be considered for prosthetic device infections or where other agents are unsuitable.
Off‑label use requires specialist oversight and informed consent with a clear monitoring plan.
Checklist for documenting off‑label use:
- Document rationale and why alternatives were unsuitable.
- Record which alternatives were tried and their outcomes.
- Set out a monitoring plan including weekly CBC and visual checks.
Key Clinical Findings (Australia & International Evidence)
What does the evidence say about efficacy and safety?
Clinical trials and reviews indicate linezolid is effective for MRSA skin infections and has comparable or superior outcomes to vancomycin for some MRSA pneumonia endpoints.
There is a trade‑off with safety: higher rates of thrombocytopenia and neuropathy have been observed with prolonged use.
Linezolid is also effective for VRE bloodstream and tissue infections where alternatives are limited.
Practical point: efficacy must be balanced against adverse effect risk and stewardship oversight is recommended.
| Infection Type | Efficacy Summary | Key Safety Concerns |
|---|---|---|
| MRSA Skin Infection | Effective; useful after other antibiotics fail | Nausea, thrombocytopenia with prolonged use |
| MRSA Pneumonia | Comparable or superior to vancomycin for some endpoints | Higher myelosuppression risk if prolonged |
| VRE Infections | Effective option where alternatives are limited | Peripheral/optic neuropathy with prolonged courses |
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
Which antibiotics compete with linezolid for resistant Gram‑positive infections?
| Drug | Class | Typical Use | Key Pros/Cons | PBS Notes |
|---|---|---|---|---|
| Vancomycin | Glycopeptide | Serious MRSA infections | Requires therapeutic drug monitoring; nephrotoxicity risk | PBS status varies by indication |
| Daptomycin | Lipopeptide | MRSA bacteremia and complicated skin infections | Requires CPK monitoring; not for pneumonia | PBS listing dependent on criteria |
| Tigecycline | Glycylcycline | Complicated intra‑abdominal and skin infections | GI side effects and potential hepatic effects | Restricted PBS use in some settings |
| Tedizolid | Oxazolidinone | Similar spectrum to linezolid | Shorter course options and possibly less myelosuppression | PBS availability limited |
Pros And Cons Checklist
- Vancomycin: needs renal dosing checks and TDM; infusion reactions possible.
- Daptomycin: monitor creatine kinase; not indicated for pneumonia.
- Tigecycline: high rates of nausea; monitor liver function.
- Tedizolid: may offer shorter courses and potentially lower myelosuppression risk, but access and PBS coverage vary.
Common Questions (Australian Pharmacy Consultations)
What do patients ask most about zyvox and linezolid?
Typical questions include safety of long‑term use, need for blood tests, interactions with SSRIs, driving safety, cheaper generics and storage of the oral suspension.
Short answers for quick reference: weekly CBC is needed if therapy exceeds two weeks; avoid MAO inhibitors and review SSRIs with prescriber; do not drive if symptomatic; check with the pharmacist about generics and PBS subsidy; store suspension as advised on the label.
Consider a printable one‑page FAQ for patients to take home covering the main points and red flags.
Price & Access Comparison Table
How do price and access vary across sources?
| Source | Product | Typical Retail Price Range | PBS Subsidy Status | Prescription Required |
|---|---|---|---|---|
| National Chain Pharmacy | Tablet / Suspension / IV | Varies by brand and generic supplier | Depends on indication | Yes |
| Community Pharmacy | Tablet / Suspension | Varies; call ahead for stock | Depends on PBS listing | Yes |
| Online Australian Pharmacy | Tablet / Suspension | Varies; delivery fees may apply | Depends on indication and prescription type | Yes |
| Hospital Supply / OPAT | IV | Funded via hospital arrangements | Not retail | Prescriber only |
Access checklist: confirm local stock, consider OPAT for rural patients needing IV therapy and confirm laboratory access for weekly monitoring.
Registration & Regulation
TGA Approval
What should pharmacists verify before supply?
Check the TGA database for the product sponsor, AUST R number and approved indications prior to dispensing.
Keep records of the prescription, counselling and monitoring as part of professional indemnity expectations.
PBS Subsidy Details
How to check PBS rules?
PBS listings can be indication‑specific and are periodically updated.
Consult the PBS schedule for current subsidy criteria and whether an authority prescription is required.
Regulatory pre‑dispensing checklist: TGA entry confirmed, PBS item number identified, patient concession status verified.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
How should patients store zyvox at home, especially in summer?
Tablets should be stored below 30°C and protected from humidity and sunlight.
After reconstitution, the oral suspension should be stored at 20–25°C, not refrigerated, and used within 21 days.
IV vials should be stored at room temperature and protected from light.
In hot or humid regions advise insulated transport and avoidance of leaving medicines in cars.
- Patient storage tips: keep in original container, avoid bathrooms, use cool cabinets during summer and never leave in a hot car.
- Pharmacy dispensing checklist for seasons: advise insulated packing for dispatch and confirm suspension stability on the label.
Cold‑Chain Handling For Pharmacies
Does linezolid need refrigeration in the pharmacy?
Linezolid does not require refrigeration but maintain controlled ambient storage below 30°C.
Monitor stock rotation and expiry dates during hot months and follow manufacturer instructions for IV reconstitution and administration timelines.
Use a pharmacy SOP checklist and temperature log to document ambient storage conditions.
Guidelines For Proper Use (Pharmacist Counselling & Patient Actions)
Australian Pharmacist Counselling Style
What should pharmacists cover in a counselling session about zyvox?
Confirm the indication and explain the adult dosing of 600 mg every 12 hours.
Emphasise the need for weekly CBC if treatment extends beyond two weeks.
Warn about the risk of serotonin syndrome when taken with SSRIs or MAO inhibitors and advise visual and neuropathic symptom monitoring.
Explain storage, missed dose advice and driving/work safety precautions.
Document counselling in the patient notes and provide a printed information sheet where possible.
- Counselling checklist: dose and timing, common side effects, red flags (bleeding, visual change, numbness), interaction review, monitoring plan, storage instructions.
Patient Advice From PBS And National Health Authorities
When should patients seek urgent care?
Advise patients to seek urgent medical attention for fever, unexpected bruising or bleeding, sudden visual changes, new numbness or tingling, severe persistent nausea or vomiting, or symptoms suggesting lactic acidosis.
Reinforce that linezolid is a critical reserve antibiotic and that adherence to monitoring helps protect both the patient and the wider community from harm.
- Red‑flag symptoms: fever with sore throat, unexplained bleeding, sudden loss of vision, progressive pins and needles, severe abdominal pain and vomiting.
- Contact actions: phone GP or local emergency department for urgent symptoms; contact local pharmacist for counselling and routine queries.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 9-14 days |
| Geelong | Victoria | 9-14 days |
| Cairns | Queensland | 14-21 days |
| Townsville | Queensland | 14-21 days |
Final Notes
Zyvox (linezolid) is a valuable reserve antibiotic best used under specialist guidance for multi‑drug resistant Gram‑positive infections.
Ensure all supplies are backed by a valid prescription, baseline blood tests where appropriate, and a clear follow‑up plan for monitoring.
When counselling, record interactions, document advice about driving and workplace safety and provide a clear list of red‑flag symptoms to the patient.
If in doubt about PBS subsidy, TGA registration or product sponsor details, consult official TGA and PBS resources before supply.
For routine queries or to arrange a follow‑up call, contact the dispensing pharmacist or the treating clinician.